Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

CompletedOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

January 8, 2023

Study Completion Date

June 8, 2023

Conditions

Oncologic Complications

Trial Locations (1)

Irccs San Matteo Pavia, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER